158 related articles for article (PubMed ID: 20421451)
1. PLD1-dependent PKCgamma activation downstream to Src is essential for the development of pathologic retinal neovascularization.
Zhang Q; Wang D; Kundumani-Sridharan V; Gadiparthi L; Johnson DA; Tigyi GJ; Rao GN
Blood; 2010 Aug; 116(8):1377-85. PubMed ID: 20421451
[TBL] [Abstract][Full Text] [Related]
2. Activation of cytosolic phospholipase A2 downstream of the Src-phospholipase D1 (PLD1)-protein kinase C γ (PKCγ) signaling axis is required for hypoxia-induced pathological retinal angiogenesis.
Zhang Q; Wang D; Singh NK; Kundumani-Sridharan V; Gadiparthi L; Rao ChM; Rao GN
J Biol Chem; 2011 Jun; 286(25):22489-98. PubMed ID: 21536681
[TBL] [Abstract][Full Text] [Related]
3. Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization.
Singh NK; Hansen DE; Kundumani-Sridharan V; Rao GN
Blood; 2013 Mar; 121(10):1911-23. PubMed ID: 23319572
[TBL] [Abstract][Full Text] [Related]
4. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling.
Xu Z; Yu Y; Duh EJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4059-66. PubMed ID: 16936124
[TBL] [Abstract][Full Text] [Related]
7. TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells.
Kim YM; Kim YM; Lee YM; Kim HS; Kim JD; Choi Y; Kim KW; Lee SY; Kwon YG
J Biol Chem; 2002 Mar; 277(9):6799-805. PubMed ID: 11741951
[TBL] [Abstract][Full Text] [Related]
8. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.
Ojima T; Takagi H; Suzuma K; Oh H; Suzuma I; Ohashi H; Watanabe D; Suganami E; Murakami T; Kurimoto M; Honda Y; Yoshimura N
Am J Pathol; 2006 Jan; 168(1):331-9. PubMed ID: 16400034
[TBL] [Abstract][Full Text] [Related]
9. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
[TBL] [Abstract][Full Text] [Related]
10. Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity - an in vitro mechanism study for preventing destructive repair of osteonecrosis.
Cao HJ; Zheng LZ; Wang N; Wang LY; Li Y; Li D; Lai YX; Wang XL; Qin L
Bone; 2015 May; 74():58-68. PubMed ID: 25554601
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation.
Spring K; Chabot C; Langlois S; Lapointe L; Trinh NT; Caron C; Hebda JK; Gavard J; Elchebly M; Royal I
Blood; 2012 Sep; 120(13):2745-56. PubMed ID: 22898603
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization.
Watanabe D; Takagi H; Suzuma K; Suzuma I; Oh H; Ohashi H; Kemmochi S; Uemura A; Ojima T; Suganami E; Miyamoto N; Sato Y; Honda Y
Am J Pathol; 2004 May; 164(5):1827-35. PubMed ID: 15111329
[TBL] [Abstract][Full Text] [Related]
13. Novel Small Molecule JP-153 Targets the Src-FAK-Paxillin Signaling Complex to Inhibit VEGF-Induced Retinal Angiogenesis.
Toutounchian JJ; Pagadala J; Miller DD; Baudry J; Park F; Chaum E; Morales-Tirado V; Yates CR
Mol Pharmacol; 2017 Jan; 91(1):1-13. PubMed ID: 27913654
[TBL] [Abstract][Full Text] [Related]
14. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
[TBL] [Abstract][Full Text] [Related]
15. Specific involvement of SRC family kinase activation in the pathogenesis of retinal neovascularization.
Werdich XQ; Penn JS
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5047-56. PubMed ID: 17065526
[TBL] [Abstract][Full Text] [Related]
16. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression.
Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A
Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435
[TBL] [Abstract][Full Text] [Related]
17. Novel role of reactive oxygen species-activated Trp melastatin channel-2 in mediating angiogenesis and postischemic neovascularization.
Mittal M; Urao N; Hecquet CM; Zhang M; Sudhahar V; Gao XP; Komarova Y; Ushio-Fukai M; Malik AB
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):877-87. PubMed ID: 25675998
[TBL] [Abstract][Full Text] [Related]
18. Proline-rich tyrosine kinase 2 via enhancing signal transducer and activator of transcription 3-dependent cJun expression mediates retinal neovascularization.
Kumar R; Singh NK; Rao GN
Sci Rep; 2016 May; 6():26480. PubMed ID: 27210483
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.
Kalishwaralal K; Sheikpranbabu S; BarathManiKanth S; Haribalaganesh R; Ramkumarpandian S; Gurunathan S
Angiogenesis; 2011 Mar; 14(1):29-45. PubMed ID: 21061058
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
